Smart Money Alert

Divi's Laboratories Limited

DecreasedInsider

DIVISLABPharmaceuticalsMarket Cap₹2.5L Cr

Deal value

₹5.84 Cr

Stake

0.02%

6,234

Trade date

10 Sept 2026

Since alert+1.5%₹9,198.00 → ₹9,340.00

Nifty 50−2.6%

PRASAD Y.T.S.

Insider

The move

Prasad Y.T.S. sold 6,234 shares of Divi's Laboratories for ₹5.84 Cr at ₹9363.77 apiece through a market sale.

About Divi's Laboratories Limited

Visit stock

A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.

Get the next move the moment it happens.

Follow the investors and Divi's Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Divi's Laboratories Limited shareholders All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Divi's Laboratories Limited

LICDecreased

LIC trimmed its stake in Divi's Laboratories from 2.53% to 1.59%, selling 24,80,972 shares.

6 Oct 2026

Government Pension Fund Global (Norway)Decreased

Government Pension Fund Global (Norway) sold 3,00,366 shares of Divi's Laboratories, trimming its stake from 1.23% to 1.12%.